Aton (EPA:ALTAO)
0.0064
-0.0002 (-3.03%)
Nov 12, 2026, 11:45 AM CET
Aton Market Cap
Aton has a market cap or net worth of €5.3 million as of November 11, 2026. It is the 43,927th most valuable company in the world and the 584th biggest in France. Its market cap has decreased by 13.51% in one year.
Market Cap
5.30M
Enterprise Value
9.70M
Revenue
602.00K
Global Rank
Country Rank
#584 France
PE Ratio
n/a
ChartMarket Cap Chart
Since October 15, 2019, Aton's market cap has increased from 5.02M to 5.30M, an increase of 5.55%. That is a compound annual growth rate of 0.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 5.30M | -11.11% |
| Dec 31, 2025 | 5.96M | -24.72% |
| Dec 31, 2024 | 7.92M | 1.62% |
| Dec 29, 2023 | 7.79M | -53.93% |
| Dec 30, 2022 | 16.92M | -44.59% |
| Dec 31, 2021 | 30.53M | -41.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 18.12M |
| GenSight Biologics | 17.57M |
| Biophytis | 14.60M |
| Aelis Farma | 11.96M |
| TME Pharma | 10.07M |
| Advicenne | 9.54M |
| Poxel | 8.29M |
| NFL Biosciences | 5.03M |